Treatment of Perinatal Opioid Use Disorder via Telemedicine
Recorded On: 11/04/2020
This is the sixth webinar in the telehealth series for the Opioid Response Network (ORN).
The webinar will describe the use of telemedicine to create integrated mental health and substance use disorder treatment services for pregnant and postpartum women receiving prenatal care in an obstetric setting. The webinar will describe outcomes for pregnant women with Opioid Use Disorder and how technology is being leveraged during COVID-19 to improve detection and treatment of maternal mental health and substance use disorders.
Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Constance Guille, MD
Dr. Constance Guille is a Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at the Medical University of South Carolina (MUSC) and director of the Women’s Reproductive Behavioral Health Division at MUSC. This division provides mental health and substance use disorder treatment to pregnant and postpartum women and conducts clinical research that aims to improve the identification and treatment of peripartum mental health and substance use disorders. Dr. Guille receives research support through National Institute on Drug Abuse and foundations such as the Duke Endowment to develop treatments that leverage technology to improve maternal health.
Julie Kmiec, DO, FAOAAM (Moderator)
Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Assistant Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program, Bridge Clinic, and is the founding medical director of the Narcotic Addiction Treatment Program’s Buprenorphine Clinic at WPIC. Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the President of the American Osteopathic Academy of Addiction Medicine.